Saccharomyces boulardii

Saccharomyces boulardii CNCM I-745 is the first yeast to be demonstrated to have probiotic properties and the first probiotic in human medicine.* 
The yeast has been investigated in more than 100 clinical trials and has been available as a probiotic treatment for diarrhea for over 56 years! Almost 500 million people have been treated with the unique strain Saccharomyces boulardii CNCM I-745 since the 1980s, and it is used in more than 90 countries.

S. boulardii CNCM I-745 is a probiotic with a unique and long history whose story continues to this very day!

------------------------------
*Joly, F et al. 2017. Saccharomyces boulardii CNCM I-745. Marteau, P and Dore J (Ed.), Gut Microbiota: A full-fledged organ. 2017: 305-326. Paris: John Libbey Eurotext.